Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
950210:KRX
Prestige Biopharma Ltd
₩9,220.00
+0.44%
(+40.00) 1D
Apr 24, 3:30:17 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 950210...
Open
₩9,120
High
₩9,250
Low
₩9,060
Mkt. cap
554.09B
Avg. vol.
91.50K
Volume
45.41K
P/E ratio
36.65
52-wk high
₩20,000
52-wk low
₩8,900
EPS
₩252
Shares outstanding
60.10M
No. of employees
54
News stories
From sources across the web
About Prestige Biopharma Ltd
CEO-
Employees54
Founded2015
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
3.34B
5.53B
2.36B
7.70B
Cost of goods sold
-
26.56B
2.23B
10.04B
Cost of revenue
-
26.56B
2.23B
10.04B
Research and development expenses
-
19.12B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.69B
-38.53B
24.95B
16.34B
Operating expense
18.69B
-7.49B
24.95B
16.34B
Total operating expenses
18.69B
19.08B
27.18B
26.38B
Operating income
-15.35B
-13.55B
-24.82B
-18.67B
Other non operating income
61.54B
-58.89B
4.06B
-1.41B
EBT including unusual items
46.20B
-9.32B
-20.76B
-20.08B
EBT excluding unusual items
46.20B
-68.78B
-20.76B
-20.08B
Income tax expense
-1.48M
-229.95M
-69.96M
-16.89M
Effective tax rate
-
2.47%
0.34%
0.08%
Other operating expenses
-
520.59M
-
-
Net income
50.46B
-8.78B
-12.62B
-15.07B
Net profit margin
1,510.87%
-158.81%
-534.55%
-195.54%
Earnings per share
-
-
-
-
Interest and investment income
-
9.14B
-
-
Interest expense
-
-7.63B
-
-
Net interest expenses
-
1.51B
-
-
Depreciation and amortization charges
-
8.61B
-
-
EBITDA
-11.28B
-8.10B
-19.37B
-13.22B
Gain or loss from assets sale
-
6.70M
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more